Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib
Descrição
Deciding between one-step and two-step irreversible inhibition mechanisms on the basis of “kobs” data: A statistical approach
Prolonged and tunable residence time using reversible covalent kinase inhibitors
Tyrosine Kinase: Most Up-to-Date Encyclopedia, News & Reviews
Full article: Drug delivery targets and strategies to address mast cell diseases
Advances in covalent kinase inhibitors - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C9CS00720B
Development of covalent inhibitors: Principle, design, and application in cancer - Zheng - 2023 - MedComm – Oncology - Wiley Online Library
Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK)
Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors. - Abstract - Europe PMC
Proteomics and Beyond: Cell Decision-Making Shaped by Reactive Electrophiles: Trends in Biochemical Sciences
de
por adulto (o preço varia de acordo com o tamanho do grupo)
